News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 28, 2015
Anika Therapeutics CEO Dr. Charles H. Sherwood to be Honored at UMass Amherst Undergraduate Commencement Ceremony on May 8
-
Apr 28, 2015Product Revenue Grows 8% to $15.5 Million
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (HA) technology, today reported...
-
Apr 28, 2015Research Demonstrates Positive Clinical Outcomes for Hyalofast®
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today announced...
-
Apr 17, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today announced...
-
Apr 15, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2015 financial results after the close of the market on Tuesday,...
-
Apr 10, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Hyalomatrix, a unique advanced wound care device based on hyaluronic acid (HA) technology, is now eligible for reimbursement as a skin substitute through the...
-
Apr 8, 2015CE Marked Cartilage Regeneration Product Has Demonstrated Positive Outcomes Internationally
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today announced...
-
Mar 17, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the 10th...
-
Feb 25, 2015Monovisc® Receives Unique J-Code Assignment from CMS Effective January 1, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today reported...
-
Feb 19, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has appointed Glenn R. Larsen, Ph.D., as a new independent member of its Board of Directors. Dr....
-
Feb 12, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end 2014 financial results after the close of the market on
-
Feb 11, 2015
BEDFORD, Mass--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today announced...
-
Nov 10, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Center for Medicare & Medicaid Services ("CMS") has assigned a unique Healthcare Common Procedure...
-
Oct 29, 2014Earnings per Share Increase to $0.40 from $0.33
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today reported...
-
Oct 16, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2014 financial results after the close of the market on...
-
Aug 4, 2014Presentation to be Webcast Live at 10:30 a.m. ET
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the...
-
Jul 30, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has entered into a new agreement with Medline Industries, Inc. to commercialize the Company's...
-
Jul 30, 2014Total Revenue Grows 26% to $26.3 Million
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today reported...
-
Jul 15, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2014 financial results after the close of the market on...
-
Apr 29, 2014Receives $17.5 Million in Monovisc® Milestone Payment
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Apr 16, 2014
BEDFORD, Mass--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2014 financial results after the close of the market on Tuesday,...
-
Apr 15, 2014Company's Commercial Partner, DePuy Synthes Mitek Sports Medicine, Records First Commercial Sale of Single-Injection Treatment for Osteoarthritis Knee Pain
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Mar 13, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Mar 4, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the 9th...
-
Feb 26, 2014Monovisc® Achieves FDA Approval
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...